Ad is loading...
IYSYX
Price
$19.77
Change
+$0.29 (+1.49%)
Updated
Nov 22 closing price
VSMAX
Price
$123.45
Change
+$1.87 (+1.54%)
Updated
Nov 22 closing price
Ad is loading...

IYSYX vs VSMAX

Header iconIYSYX vs VSMAX Comparison
Open Charts IYSYX vs VSMAXBanner chart's image
Delaware Ivy Smid Cap Core Fund
Price$19.77
Change+$0.29 (+1.49%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Index
Price$123.45
Change+$1.87 (+1.54%)
VolumeN/A
CapitalizationN/A
IYSYX vs VSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IYSYX vs. VSMAX commentary
Nov 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IYSYX is a Buy and VSMAX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VSMAX has more cash in the bank: 151B vs. IYSYX (372M). VSMAX pays higher dividends than IYSYX: VSMAX (1.42) vs IYSYX (0.59). IYSYX was incepted earlier than VSMAX: IYSYX (21 years) vs VSMAX (24 years). IYSYX is a more actively managed with annual turnover of: 13.00 vs. VSMAX (12.00). IYSYX has a lower initial minimum investment than VSMAX: IYSYX (0) vs VSMAX (3000). VSMAX (34.52) and IYSYX (33.58) have marching annual gain over last year. VSMAX return over 5 years is better than : 63.57 vs. IYSYX (5.61).
IYSYXVSMAXIYSYX / VSMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence21 years24 years-
Gain YTD20.60021.10098%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets372M151B0%
Annual Yield % from dividends0.591.4242%
Returns for 1 year33.5834.5297%
Returns for 3 years-21.3912.56-170%
Returns for 5 years5.6163.579%
Returns for 10 years1.15130.291%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOPE166.454.32
+2.66%
Grand Canyon Education
MPWR580.818.34
+1.46%
Monolithic Power Systems
CIM14.660.04
+0.27%
Chimera Investment Corp
INKT0.68-0.01
-1.46%
MiNK Therapeutics
ME3.11-0.12
-3.72%
23andMe Holding Co